Loncar Cancer Immunotherapy ETF (CNCR) slipped -6.08% or -1.74 to $26.79. It is approximately 58480 shares traded, which is 182.21% compare to the average total volume 32095. The market cap of CNCR is $66.96 million. The year to date change is 16.5%. The 52 week price range is from $21.09 to $32.32. Price of CNCR have changed 0.60% during last week. It have changed 8.11% over last month, -665.76% over last 3 months, 16.32% over last 6 months and 32.39% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CNCR is 27.62. It is 3.10% above current price. The 200-day Moving Averages for CNCR is 26.48. It is -1.16% below current price. The 52-week High is 32.32. It is 20.64% from the current price. The 52-week Low is 21.09. It is -21.28% from current price.
There are some statistics of CNCR. It is has market cap $66.96 million. The share outstanding is 2.50 million. The average volume is 32095. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CNCR is -31.33%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CNCR is -28.04%.